Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
We downregulated UNC5B-AS1 using small interfering RNA and carried out assays of cell proliferation, colony formation, migration and invasion to explore the function of UNC5B-AS1 in PTC cell lines (TPC1 and BCPAP).
|
30805847 |
2019 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Furthermore, we found that over-expression of miR-206 could notably decrease the IC<sub>50</sub> values both in TPC-1 and TPC-1/euthyrox cells, which indicated that miR-206 played an essential role in the euthyrox resistance in PTC.
|
30904818 |
2019 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Human thyroid epithelial cell line Nthy-ori3-1and PTC cell lines (BCPAP, K1, HTH83, and TPC-1) were cultured.
|
31646573 |
2019 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
PTC cell lines K1 and TPC-1 were stimulated with IL-17A and analyzed for MHC class I expression afterwards.
|
31159823 |
2019 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The expression of RUNX2-upstream genes was evaluated by real-time PCR in Nthy-Ori 3-1 normal thyroid cells and TPC1 and BHP10-3 PTC cell lines.
|
31043660 |
2019 |
Papillary thyroid carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In the present study, we identified that KMT5A was elevated in 50 pairs of papillary thyroid cancer tissue samples and in cell lines K1 and TPC-1 by qRT-PCR and western blotting, as well as by immunohistochemical staining.
|
29512765 |
2018 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Rg3 apparently inhibited the migration and invasion in four papillary thyroid cancer (PTC) cells (TPC-1, BCPAP, C643, and Ocut-2c cells) and pulmonary metastasis in lung metastasis model of C643 cells in nude mice.
|
30136914 |
2018 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The human TPC‑1 thyroid gland papillary carcinoma cell line was used to investigate the molecular mechanisms underlying the roles of miR‑9 in PTC.
|
29767243 |
2018 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Effects of different extracts of curcumin on TPC1 papillary thyroid cancer cell line.
|
29448931 |
2018 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The role of miR-222 in PTC cell migration ability was assessed with Transwell<sup>®</sup> assays and wound-healing assays in both TPC-1 and K1 cells.
|
29882471 |
2018 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
NEAT1_2 expression was markedly increased in PTC tissues and the PTC cell lines (K1 and TPC1).
|
29515109 |
2018 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Matrine is a traditional Chinese medicine and has been demonstrated as a promising alternative drug for the treatment of TPC-1 human PTC.
|
30127885 |
2018 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The functions of the ZCCHC12 gene in PTC cell lines (TPC1 and BCPAP) transfected with small interfering RNA were determined through cell colony formation assay, migration assay, and invasion assay.
|
28424903 |
2017 |
Papillary thyroid carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, the results of the present study suggested that LAPTM4B*2 was a susceptibility factor for PTC in the female Chinese population and this may not be caused by the transcriptional regulation of LAPTM4B polymorphism region in TPC1 and B-CPAP cell lines.
|
28927096 |
2017 |
Papillary thyroid carcinoma
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
MATERIAL AND METHODS Four cell lines included TPC-1 (BRAFWT/WT), BCPAP (BRAFV600E/V600E), PCCL3, and PTC3-5 (RET/PTC), were grown in culture in vitro with or without suppression of NF-κB using pyrrolidine dithiocarbamate (PDTC), and cell proliferation, and cell migration were evaluated.
|
29117154 |
2017 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
In the present study, CD44<sup>+</sup>/CD24<sup>-</sup> cells were isolated from the TPC-1 PTC cell line and biological function assays revealed that CD44<sup>+</sup>/CD24<sup>-</sup> cells were significantly more proliferative and chemoresistant compared with CD44<sup>-</sup>/CD24<sup>-</sup> cells.
|
29201169 |
2017 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
Induction of epithelial to mesenchymal transition (EMT) by transforming growth factor (TGF)-beta in a PTC cell line (TPC1) led to increased MALAT1 expression, supporting a role for MALAT1 in EMT in thyroid tumors.
|
27696303 |
2017 |
Papillary thyroid carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
MiR-20b was overexpressed in the PTC cell lines K1 and TPC-1, and the effects on cell viability, migration, and invasion were evaluated.
|
27717302 |
2016 |
Papillary thyroid carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Moreover, the basal level of LDOC1 in two human PTC-derived cell lines (BCPAP and TPC-1) compared with normal thyroid tissue was determined.
|
26637328 |
2015 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
TPC-1 (PTC) and NTHY (normal thyroid follicular) cell lines were treated with exosome isolates and conditioned medium (CM), both containing miR-146b and miR-222.
|
25819770 |
2015 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
The recombinant expression vector pcDNA3.1 (+)-TMP21 and specific small interfering RNAs (siRNA) against TMP21 were transfected into a papillary thyroid cancer cell line (TPC1).
|
26617795 |
2015 |
Papillary thyroid carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Next, to explore the potential function of miR-96, PTC cell lines K1 and TPC1 were transiently transfected with miR-96 mimics and inhibitor.
|
26617698 |
2015 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
MTT assays, colony formation assays, apoptosis assays were used to explore the potential function of miR-181b inhibitor in TPC1 human thyroid papillary cancer cells.
|
25550803 |
2014 |
Papillary thyroid carcinoma
|
0.100 |
Biomarker
|
disease |
BEFREE |
In this study, we investigated the effect of NTP on invasion or metastasis, as well as the mechanism by which plasma induces anti-migration and anti-invasion properties in human thyroid papillary cancer cell lines (BHP10-3 and TPC1).
|
24667444 |
2014 |
Papillary thyroid carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Moreover, PDPN mRNA and protein were highly expressed in PTC-derived TPC1 and BcPAP cell lines but were not detected in follicular thyroid cancer derived cell lines.
|
24797369 |
2014 |